In a worrying trend, a recent study by the Israeli health ministry on Friday, revealed that Pfizer’s Covid-19 vaccine is less effective at preventing infection and symptomatic cases from the Delta variant of the Coronavirus (COVID-19). The study stated that the Pfizer-BioNTech vaccine was 39% effective at preventing infections and 41% effective at preventing symptomatic infections from the Delta variant, which is lower than the early estimates of 64%. Pfizer is currently seeking US CDC's approval for a booster dose for those vaccinated.
Pfizer’s Covid-19 vaccine is less effective at preventing the Delta variant
This website uses cookies to manage authentication, navigation, and other functions. By using our website, you agree that we can place these types of cookies on your device.
A cookie is a text file being stored in your device: Computer, Smartphone, etc.
Be aware if you decline to store cookies you will neither be able to Register or Login!
This website uses cookies to manage authentication, navigation, and other functions. By using our website, you agree that we can place these types of cookies on your device.
A cookie is a text file being stored in your device: Computer, Smartphone, etc.
Be aware if you decline to store cookies you will neither be able to Register or Login!